subscribe to the blog

Receive email updates from the WSDA Blog.

Entries in Regulatory (44)



On Friday, September 12th, the Dental Quality Assurance Commission (DQAC) held a public meeting to discuss ongoing business. Here are some of the current issues before the commission:

Click to read more ...


WSDA Fights back: Corporate Practices

 For decades, many of Washington’s dentists have expressed concern, angst, and frustration over the corporate dental practice model. These emotions have arisen over concerns about quality of care and the often clandestine nature of these entities. Many dentists, including several who have worked for corporate dental organizations as associate dentists, do not completely understand their ownership structure, business relationship with the management group, and ultimately where the buck stops. Without transparency and clarity, there are very legitimate questions about whether corporate practices operate legally in Washington state.

Click to read more ...


Reclassification of Hydrocodone Products

The Drug Enforcement Administration (DEA) has issued a final rule that reclassifies hydrocodone combination products (HCPs) such as Vicodin from Schedule III to Schedule II drugs. Effective October 6, 2014, this reclassification will have an impact on dentist’s ability to prescribe HCPs. Dentists that currently hold a Schedule III DEA registration will need to re-register with the DEA for Schedule II authority in order to continue prescribing hydrocodone combination products. 

Click to read more ...


Rx Regulations

Reminder: When filling a prescription for in-office use, dentists need to establish an account and order their prescription medications through a wholesaler with proper invoicing. Pharmacies that are not licensed wholesalers are not to supply medication to prescribers and are in violation of WAC 246-879-010 unless one of the below sections (a-e) apply. 

Click to read more ...